Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis.
about
A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival.Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.Daratumumab for the treatment of multiple myeloma.Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis.Mechanisms of Resistance in Multiple Myeloma.Standardisation of minimal residual disease in multiple myeloma.Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation.The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype.Progress and Paradigms in Multiple Myeloma.Autologous transplant for myeloma: when the old meets the new.Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation.Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis.BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee.High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan.The effect of novel therapies in high-molecular-risk multiple myeloma.Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and against.Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response.MRD in multiple myeloma: more questions than answers?Whither Radioimmunotherapy: To Be or Not To Be?Multiple myeloma
P2860
Q30239781-CB072976-4F59-4DA1-8177-8EFC1CC419B4Q38671390-8F01DA41-8468-49D4-98A3-3AC0C7FAD2F4Q38824538-A49567A3-8C91-4DBC-BA58-D2A15AA19233Q38971754-2ADE79D5-CEF7-4201-937C-BC5B1CC306B2Q39185604-1B4F9CA7-5D87-4F81-A96C-1DF84FA70415Q39410899-43F06789-ECF3-4218-8016-5027E87C172FQ41924881-3B59EC87-8A14-46C1-A4C9-393B90FBF96DQ42341707-4D1304E4-23DA-4ABF-8DED-F4BED9B9D460Q44694137-663C1D1C-4F50-42F3-B128-DE3DBF8B16BAQ47153254-447BBD93-1CE4-4FD8-832A-FEF602440CEDQ47164979-22118B21-4C5C-4FE9-BD0F-D74C833159E0Q47207279-1F3265F1-F179-41AB-B37E-00CD93BBC834Q47307819-C2C24BB2-C194-421E-911E-DCA2AFE522F4Q47369825-538793EE-B3CB-476E-9B4C-5E5222EB6A99Q47375990-1D5C14BD-3C63-4EF6-B301-2FAF326F6A98Q47418005-169667D3-EBCC-45AB-8023-DB7951629216Q48338656-68A63613-6F68-428C-B1B5-46543FD5A6B0Q50057591-2AC489E9-FA30-46E2-8C74-DB7367CB48D7Q50203410-4D92C524-1E5F-477B-BDEE-DD637B8C2A26Q56657250-496C7271-9699-4AAF-9EB4-EB3064D2D525
P2860
Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@en
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@en-gb
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@nl
type
label
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@en
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@en-gb
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@nl
prefLabel
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@en
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@en-gb
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@nl
P2093
P2860
P50
P6366
P1154
2-s2.0-85013092867
P1433
P1476
Association of Minimal Residua ...... iple Myeloma: A Meta-analysis.
@en
P2093
Anjan Thakurta
Anna Georgieva
J Anthony Child
Mehmet Kemal Samur
Nikhil C Munshi
Paul Sherrington
Roger G Owen
Walter M Gregory
P2860
P356
10.1001/JAMAONCOL.2016.3160
P5530
P577
2017-01-01T00:00:00Z
P6179
1038328234
P6366
2518827451